RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    여성 소아 종양 완치자의 생식샘 기능 = Gonadal Function in Female Childhood Cancer Survivors

    한글로보기

    https://www.riss.kr/link?id=A106148593

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    During the last three decades childhood cancer survivorship study has extensively developed and now we have much extent of knowledge about survivor’s long-term mortality and chronic illness. One of the many challenges that females survivors face includes reproductive health, which involves reproductive and sexual health changes that could later significantly reduce one’s quality of life. Alkylating chemotherapy, irradiation of the CNS and/or ovaries, and pelvic and genitourinary surgery can adversely affect the reproductive organs. Increased awareness of the unique needs of female cancer survivors,timely evaluation of gonadal function, and active intervention for fertility preservation before, during, and after therapy is warranted.
    번역하기

    During the last three decades childhood cancer survivorship study has extensively developed and now we have much extent of knowledge about survivor’s long-term mortality and chronic illness. One of the many challenges that females survivors face inc...

    During the last three decades childhood cancer survivorship study has extensively developed and now we have much extent of knowledge about survivor’s long-term mortality and chronic illness. One of the many challenges that females survivors face includes reproductive health, which involves reproductive and sexual health changes that could later significantly reduce one’s quality of life. Alkylating chemotherapy, irradiation of the CNS and/or ovaries, and pelvic and genitourinary surgery can adversely affect the reproductive organs. Increased awareness of the unique needs of female cancer survivors,timely evaluation of gonadal function, and active intervention for fertility preservation before, during, and after therapy is warranted.

    더보기

    참고문헌 (Reference)

    1 Boepple PA, "Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty" 7 : 24-33, 1986

    2 Chow EJ, "Timing of menarche among survivors of childhood acute lymphoblastic leukemia:a report from the Childhood Cancer Survivor Study" 50 : 854-858, 2008

    3 Parent AS, "The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration" 24 : 668-693, 2003

    4 Robison LL, "The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research" 27 : 2308-2318, 2009

    5 Oktay K, "Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?" 21 : 1345-1348, 2006

    6 Köhler TS, "Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer" 28 : 269-277, 2011

    7 Larsen EC, "Radiotherapy at a young age reduces uterine volume of childhood cancer survivors" 83 : 96-102, 2004

    8 Carter A, "Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study" 37 : 1023-1029, 2006

    9 Dillon KE, "Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy" 99 : 477-483, 2013

    10 Sklar CA, "Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study" 98 : 890-896, 2006

    1 Boepple PA, "Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty" 7 : 24-33, 1986

    2 Chow EJ, "Timing of menarche among survivors of childhood acute lymphoblastic leukemia:a report from the Childhood Cancer Survivor Study" 50 : 854-858, 2008

    3 Parent AS, "The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration" 24 : 668-693, 2003

    4 Robison LL, "The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research" 27 : 2308-2318, 2009

    5 Oktay K, "Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?" 21 : 1345-1348, 2006

    6 Köhler TS, "Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer" 28 : 269-277, 2011

    7 Larsen EC, "Radiotherapy at a young age reduces uterine volume of childhood cancer survivors" 83 : 96-102, 2004

    8 Carter A, "Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study" 37 : 1023-1029, 2006

    9 Dillon KE, "Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy" 99 : 477-483, 2013

    10 Sklar CA, "Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study" 98 : 890-896, 2006

    11 Green DM, "Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study" 187 : 1070-1080, 2002

    12 Green DM, "Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study" 28 : 2824-2830, 2010

    13 Sanders JE, "Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation" 87 : 3045-3052, 1996

    14 Donnez J, "Ovarian cortex transplantation: 60reported live births brings the success and worldwide expansion of the technique towards routine clinical practice" 32 : 1167-1170, 2015

    15 Broekmans FJ, "Ovarian aging: mechanisms and clinical consequences" 30 : 465-493, 2009

    16 Wallace WH, "Oncofertility and preservation of reproductive capacity in children and young adults" 117 (117): 2301-2310, 2011

    17 Anderson DM, "Medical and neurocognitive late effects among survivors of childhood central nervous system tumors" 92 : 2709-2719, 2001

    18 Guibout C, "Malignant breast tumors after radiotherapy for a first cancer during childhood" 23 : 197-204, 2005

    19 Blumenfeld Z, "Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors" 20 : 1283-1289, 2015

    20 Loren AW, "Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update" 31 : 2500-2510, 2013

    21 Green DM, "Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study" 27 : 2677-2685, 2009

    22 Byrne J, "Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia" 42 : 589-597, 2004

    23 Borgmann-Staudt A, "Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence" 47 : 271-276, 2012

    24 Metzger ML, "Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications" 31 : 1239-1247, 2013

    25 Blumenfeld Z, "Endocrine prevention of chemotherapy-induced ovarian failure" 28 : 223-229, 2016

    26 Chemaitilly W, "Endocrine complications in longterm survivors of childhood cancers" 17 : R141-R159, 2010

    27 Carel JC, "Consensus statement on the use of gonadotropin-releasing hormone analogs in children" 123 : e752-e762, 2009

    28 Signorello LB, "Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study" 30 : 239-245, 2012

    29 Oosterhuis BE, "Concerns about infertility risks among pediatric oncology patients and their parents" 50 : 85-89, 2008

    30 Carel JC, "Clinical practice. Precocious puberty" 358 : 2366-2377, 2008

    31 Diller L, "Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings" 27 : 2339-2355, 2009

    32 Kenney LB, "Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study" 141 : 590-597, 2004

    33 Lunsford AJ, "Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors" 101 : 227-231, 2014

    34 Knauff EA, "Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure" 94 : 786-792, 2009

    35 La Marca A, "Anti-Mullerian hormone (AMH):what do we still need to know?" 24 : 2264-2275, 2009

    36 Korea Central Cancer Registry, National Cancer Center, "Annual report of cancer statistics in Korea in 2013" Ministry of Health and Welfare 1-194, 2015

    37 Chemaitilly W, "Acute ovarian failure in the childhood cancer survivor study" 91 : 1723-1728, 2006

    38 Armstrong GT, "Abnormal timing of menarche in survivors of central nervous system tumors:A report from the Childhood Cancer Survivor Study" 115 : 2562-2570, 2009

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 재인증평가 신청대상 (재인증)
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2019-12-01 등재 등재후보로 하락 (계속평가) KCI등재후보
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2014-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.1 0.1 0
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0 0 0 0
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼